// App-Quantinova.ai

T4146 2015 AHA : Therapeutic Inhibition of Mitochondrial Reactive Oxygen Species with Mito-tempo Reduces Diabetic Cardiomyopathy

Researchers

Presenter

  • Tianqing Peng

Principal Investigators

  • N/A

Medical Centers

  • Lawson Health Res Inst, London, ON, Canada

  • London, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Diabetic cardiomyopathy

  • Myocardial Dysfunction

  • Type 1 diabetes mellitus

  • Heart muscle disease

  • Diabetes

Biomarkers

  • Mitogen-activated protein kinase 3

  • Proto-oncogene tyrosine-protein kinase ROS

Drug/Treatment

  • Streptozotocin

  • Aluminum hydroxide / magnesium hydroxide / simethicone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved